Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for sialorrhea in cerebral palsy
IRCT20220211053995N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of botulinum toxin type A in cerebral palsy (CP) and hypersalivation, sponsored by Mashhad University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)hypersalivation
Beyond the preview
Go deeper on IRCT20220211053995N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220211053995N1.